Hap Trading, LLC Blueprint Medicines Corp Put Options Transaction History

Hap Trading, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 12, 2022	SELL	$54.1 - $110.08 $541,000 - $1.1 Million	-10,000 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$80.98 - $109.47 $809,800 - $1.09 Million	10,000 New	10,000 $24,000
Q1 2021 May 14, 2021	SELL	$90.71 - $108.28 $18.8 Million - $22.4 Million	-207,100 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$92.08 - $124.48 $16.8 Million - $22.7 Million	182,000 Added 725.1%	207,100 $515,000
Q4 2019 Feb 11, 2020	BUY	$66.73 - $82.59 $1.67 Million - $2.07 Million	25,100 New	25,100 $15,000

351

60.3M

2.25M

1.18M

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.4B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.